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Introduction
Cellular senescence is an irreversible cell cycle exit that is a key 
tumor suppressor mechanism and also directly contributes to 
aging (López-Otín et al., 2013). Indeed, clearance of senescent 
cells can improve aging phenotypes (Baker et al., 2011, 2016). 
Senescence is characterized by proliferation arrest, increase in 
cell size and mitochondrial mass together with mitochondrial 
dysfunction, and increased secretion of proinflammatory and 
pro-oxidant signals (Passos et al., 2007, 2010; Rodier et al., 
2009; López-Otín et al., 2013). This increase in cell growth 
and metabolism is supported in part by mTORC1 (Zhang et 
al., 2000; Demidenko and Blagosklonny, 2008; Carroll et al., 
2013; Xu et al., 2013; Herranz et al., 2015; Correia-Melo et 
al., 2016), a conserved serine/threonine kinase that specifically 
regulates protein translation and nucleotide and lipid biogenesis 
and inhibits the catabolic process of autophagy (Laplante and 
Sabatini, 2012; Carroll et al., 2015).
Amino acids are necessary and sufficient for mTORC1 
activation, the magnitude of which is greatly enhanced in the 
presence of growth factors (Hara et al., 1998; Long et al., 2005; 
Carroll et al., 2016). Growth factors signal via phosphoinositide 
3-kinase (PI3K)/Akt and tuberous sclerosis complex (TSC1/2) 
to activate the small GTPase Rheb, which is the master activa-
tor of mTORC1 (Dibble and Cantley, 2015). TSC2 localization 
to the lysosome, and therefore Rheb activity, is controlled by 
availability of growth factors and amino acids, specifically ar-
ginine, (Demetriades et al., 2014; Menon et al., 2014; Carroll 
et al., 2016). Amino acids further regulate mTORC1 activity 
by controlling its localization at the lysosome via the signal-
ing cascade upstream of Ragulator complex and Rag GTPases 
(Laplante and Sabatini, 2012). Starvation of growth factors or 
amino acids inhibits mTORC1 and activates autophagy. Au-
tophagy involves the engulfment of cytoplasmic contents into 
double membrane–bound vesicles called autophagosomes, 
which fuse with lysosomes, degrading their contents, which are 
subsequently released into the cytoplasm (Carroll et al., 2015). 
Starvation therefore shifts the cell from an anabolic to a cata-
bolic program to liberate nutrients and ensure cell survival.
mTORC1 activity promotes senescence phenotypes; how-
ever, it is unclear how mTORC1 signaling differs in senescent 
versus young cells. Indeed, its activity appears to be only mod-
erately elevated in senescence (Demidenko and Blagosklonny, 
2008; Dalle Pezze et al., 2014; Correia-Melo et al., 2016), al-
though it has been reported to become insensitive to serum in 
senescent cells (Zhang et al., 2000). To further understand the 
underlying mechanisms by which mTORC1 is dysregulated in 
senescence, we investigated the ability of mTORC1 and auto-
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phagy to sense and appropriately respond to changes in extra-
cellular nutrient availability in young and senescent cells.
Results and discussion
Upon removal of serum and amino acids, proliferating pri-
mary human fibroblasts (control) show a significant decrease in 
mTORC1 signaling (phospho S6 and 4EBP1) and a concomi-
tant increase in LC3B-II levels, a marker for autophagy (Fig. 1, 
a and b). In contrast, mTORC1 activity persists in the absence 
of these mitogenic signals in stress-induced senescent (20 Gy ir-
radiation), oncogene-induced senescent (B-RAFV600E transduc-
tion), and replicative senescent cells (Fig. 1, a and b; and Fig. S1 
a). This is accompanied by a lack of increase in LC3-II levels, 
although interestingly, the basal levels of LC3B-II are signifi-
cantly higher in senescent cells than in control cells (Narita et 
al., 2011). We confirmed that this phenotype is specific to senes-
cence and is not simply a result of cell cycle exit (quiescence; 
Fig. S1 a; Demidenko and Blagosklonny, 2008). Different star-
vation methods indicate that signaling pathways dependent 
on both growth factors (Zhang et al., 2000) and amino acids 
are perturbed in senescent cells. Indeed, we observed higher 
levels of phosphorylated Akt and TSC during starvation (but 
no changes in AMPK) in addition to the insensitivity of phos-
pho-S6 to any starvation protocol (Fig. 1 c). Furthermore, the 
localization of TSC2 to the lysosomes, which we have shown 
previously to be regulated by both growth factors and amino 
acids (Carroll et al., 2016), is perturbed in senescence (Fig. 1, 
d and e). This perturbation directly, but partially, contributes 
to dysregulated mTORC1, as overexpression of TSC2 reduces 
mTORC1 activity and restores some sensitivity to amino acid 
starvation (Fig. S1 b). In senescent cells, mTOR localization 
remains sensitive to starvation by relocalizing to the cytoplasm; 
however, note that after starvation, mTOR-Lamp1 colocaliza-
tion levels remain higher than in control cells, which may con-
tribute to increased mTORC1 activity (Narita et al., 2011; Fig. 
S1 c). Together, these data indicate that mTORC1 activity in 
senescent cells becomes constitutive and insensitive to external 
and internal mitogenic cues; in agreement with previous stud-
ies, this includes growth factors (Zhang et al., 2000), but we also 
demonstrate that senescent cells are insensitive to amino acid 
availability. The activity of mTORC1, however, is not necessar-
ily grossly elevated compared with proliferating, young cells.
Previous studies indicated that deficiencies in primary 
cilia formation are associated with enhanced PI3K/mTORC1 
signaling (Boehlke et al., 2010; Wang et al., 2015). We ini-
tially confirmed that indeed, Akt and mTORC1 signaling is 
enhanced in cells deficient in cilia formation (chondrocytes 
harboring an IFT88 hypomorphic mutation; Fig.  2, a and b). 
Importantly, similar to senescent cells, cilia-deficient cells are 
resistant to starvation. Akt and mTORC1 signaling persisted in 
the absence of serum and amino acids, and similar defects in 
starvation-dependent TSC2 localization to lysosomes were ob-
served (as well as the trend for higher levels of mTOR-Lamp1 
colocalization after starvation; Fig. 2, a and b; and Fig. S1, d 
and e). It is interesting to note that the similarities between se-
nescent and cilia-deficient cells extend to the observed increase 
in lysosomal content (Fig. S1, c–e). Whether this is a result of 
defective mTORC1 signaling—for example, through perturbed 
TFEB/TFE3-dependent transcriptional regulation of lysosomal 
proteins (Napolitano and Ballabio, 2016)—or a result of defec-
tive lysosomal turnover remains to be investigated. At the same 
time, we noted that upon starvation of HeLa cells, patches of 
phospho-S6–positive cells were still observed in the confluent 
monolayer, which correlates with a consistent failure of these 
cells to grow primary cilia (Fig. S1 f). Together, these data indi-
cate that PI3K/mTORC1 activity is negatively regulated by pri-
mary cilia, and signaling cannot be efficiently inhibited in their 
absence. Therefore, we asked whether a lack of cilia forma-
tion could represent the underlying mechanism of constitutive 
mTORC1 activity in senescence. Indeed, although serum star-
vation of confluent fibroblasts induced significant elongation of 
primary cilia, cilia present in senescent cells failed to elongate 
upon starvation (Fig. 2, c–f), even though the same number of 
short cilia were observed in resting conditions (Fig. 2, c and d).
Defects in cilia formation could result from differences in 
the properties of the plasma membrane in senescent cells. In-
deed, we found that the plasma membrane becomes depolarized 
upon senescence acquisition (Fig. 3 a). Interestingly, membrane 
depolarization is clearly linked to the acquisition of senescence, 
as long-term culture of fibroblasts in the presence of pinacidil 
(which can partially prevent membrane depolarization in se-
nescent cells) increases the rate of proliferation and postpones 
the onset of growth arrest (Fig. 3 b and Fig. S2, a and b). Im-
portantly, restoration of senescent fibroblast plasma membrane 
potential with pinacidil treatment not only rescued the primary 
cilia elongation defect of senescent cells (Fig. 3, c and d) but 
also promoted complete starvation-dependent inhibition of Akt 
and, to a lesser extent, mTORC1 signaling (Fig. 3 e). Interest-
ingly, pinacidil was also able to induce a small but significant 
increase in cilia length and concomitant significant decrease in 
phosphorylation of Akt and S6 in starved control fibroblasts 
(Fig. S2, c and d). Mechanistically, the effect of pinacidil on 
signaling is likely to be upstream or via the observed cilia elon-
gation, as pinacidil does not significantly reduce signaling in 
cilia-deficient cells and does not rescue the elevated signaling 
we previously observed in these cells in starved conditions (Fig. 
S2 e). Rather, pinacidil in fact increased phosphorylation of S6 
in cilia-deficient cells in starvation conditions. Together, these 
data highlight the central importance of membrane potential 
in responding appropriately to mitogenic signals and suggest 
that membrane depolarization, which is acquired during se-
nescence, leads to defects in cilia formation, which ultimately 
causes insensitivity of intracellular signaling pathways to 
nutrient availability.
Although the sensitivity of growth factor signaling was 
restored by hyperpolarization of the membrane, residual 
mTORC1 signaling was still observed (Fig. 3 e). Because cilia 
are not known to affect amino acid sensing, we hypothesized 
that additional perturbation of amino acid sensing may further 
contribute to the mTORC1 phenotype. We investigated the con-
tribution of autophagy for three main reasons. First, it is a major 
catabolic process that generates free amino acids in the cyto-
plasm (Carroll et al., 2015); indeed, in normal cells, prolonged 
periods of starvation can lead to the reactivation of mTORC1 
as a result of autophagy-derived liberation of free amino acids 
(Yu et al., 2010). Second, consistent with previous data (Narita 
et al., 2011; Dalle Pezze et al., 2014), basal autophagy levels 
are significantly higher in senescent cells, and the flux through 
the pathway is preserved (Fig. 1, a and b; and Fig. S2 f). Third, 
the amount of free amino acids per cell is increased in both fed 
and starved senescent compared with control cells, potentially 
resulting in their concentrations being sufficient for mTORC1 
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activation at localized sites, e.g., lysosomes, even during starva-
tion (although the levels are similar when normalized to protein 
levels; Fig. S2, g and h). We therefore hypothesized that in se-
nescent cells, elevated autophagy generates intracellular amino 
acids that can support mTORC1 activity even on removal of 
exogenous amino acids. To test this, we inhibited autophagy 
using chloroquine (to inhibit autophagosome degradation) or 
Atg5 siRNA (to suppress autophagosome formation). Chloro-
quine significantly restored amino acid starvation–dependent 
inhibition of mTORC1 (Fig.  3  f), whereas partial rescue was 
observed after Atg5 siRNA treatment, corresponding to partial 
knock-down efficiency achieved in senescent cells (Fig. S2 
i). In agreement with the role of persistent growth factor sig-
naling in mTORC1 phenotype in senescent cells, treatment of 
cells with an Akt inhibitor also partially restored the mTORC1 
phenotype, whereas treatment with an Akt inhibitor and chlo-
roquine completely abolished mTORC1 signaling in starved 
cells (Fig. 3 f). Importantly, the ability of chloroquine to restore 
signaling sensitivity to senescent cells is not a result of general 
mTORC1 inhibition, as it did not inhibit Akt or S6 phosphoryla-
tion in control, nonstarved cells (Fig. S2 j). Furthermore, chlo-
roquine had no effect on membrane potential or cilium length 
in senescent cells, supporting a mode of action more proximal 
to mTORC1, i.e., modulating autophagy/amino acids (Fig. S2, 
k and l). Collectively, these data support the conclusion that 
constitutive mTORC1 activity in senescent cells is supported 
by multiple independent pathways including cilia defects and 
high levels of autophagy.
Next, we investigated whether senescent cells are depen-
dent on persistent mTORC1 activity for their survival in star-
vation conditions. To test this, we used Torin1, chloroquine, 
Akt inhibitor, and pinacidil to suppress persistent mTORC1 in 
starved senescent cells (Fig. 3, e and f) and measured cell survival 
(Fig. 4, a and b; and Fig. S3 a). Indeed, compared with starvation 
alone, all of these mTORC1-inhibiting drugs induced significant 
senescent cell death (Fig. 4, a and b; and Fig. S3 a). Importantly, 
we confirmed that only minimal cell death occurred in control 
fibroblasts when starved in the presence of Torin1 for 24 h (Figs. 
4 c and S3 b). Furthermore, only in the absence of serum and 
amino acids was significant cell death induced in senescent cells 
Figure 1. PI3K/Akt/mTOR/autophagy are insensitive to starvation in senescent cells. (a) Immunoblot analysis of mTORC1 and autophagy activity in con-
trol and senescent (Sen(IR); 30 d after 20 Gy x-ray irradiation) primary human fibroblasts after overnight serum starvation with or without 1-h amino acid 
starvation. (b) As in panel a, but senescence was achieved by transduction of cells with oncogenic mutant B-RAFV600E (oncogene-induced senescence, OIS). 
(c) Immunoblot analysis of signaling cascades upstream of mTORC1 after starvation protocols as described in panel a. (d and e) Proliferating or replicative 
senescent (Sen(Rep)) cells were treated as in a, fixed, and immunostained for antibodies against TSC2 and Lamp1. White arrows indicate recruitment of 
TSC2 to lysosomes (d). Colocalization between Lamp1 and TSC2 (e) was analyzed. Error bars represent SEM; all experiments, n = 3 (for colocalization, at 
least 10 cells imaged per experimental repeat). Student’s t test performed between groups: *, P < 0.05; ***, P < 0.001; NS, not significant. Bars, 10 µm.
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(Figs. 4 c and S3 b). Further evidence that persistent mTORC1 
activity represents survival vulnerability comes from the fact 
that starvation plus Torin1 selectively kills nonsenescent TSC2−/− 
mouse embryonic fibroblasts (MEFs, which have constitutively 
active Rheb, and therefore mTORC1) compared with wild-type 
controls (Fig. S3 c). Consistent with resistance of senescent cells 
to apoptosis (Wang, 1995), we found no evidence of apoptotic 
cell death in starved senescent cells treated with Torin1. Instead, 
we found a further induction of autophagy over and above the 
increased autophagy levels in senescent cells at basal conditions 
(Fig. 4 d). Inhibition of autophagy by chloroquine 1 h before the 
observed cell death rescued Torin1-induced senescent cell death 
(Fig. 4 e). Together, these observations indicate that increased 
autophagy contributes to mTORC1 deregulation (Narita et al., 
2011) and survival of senescent cells during starvation, whereas 
persistent mTORC1 prevents further hyperactivation of autoph-
agy, which could lead to cell death (Shimizu et al., 2014).
In summary, we have identified that extensive rewiring 
occurs during the acquisition of senescence (Dalle Pezze et 
al., 2014), leading to the constitutive activation of mTORC1, 
which is resistant to both serum and amino acid starvation. Al-
though mTORC1 activity appears to be supported by autoph-
Figure 2. Senescent cells fail to induce primary cilium elongation. (a and b) Wild-type and IFT88ORPK chondrocytes (which are deficient in primary cilia; 
Wann et al., 2012) were grown until confluent and subjected to serum starvation overnight. Cells were either lysed and subjected to Western blotting (a) 
or fixed and immunostained with antibodies against acetylated tubulin and phospho-S6 (b). (c–f) Confluent control and senescent (20 Gy irradiation; Sen 
(IR)) fibroblasts were serum-starved overnight (–FCS), fixed, and immunostained for acetylated tubulin and phospho-S6 (c). Percentage of cells with primary 
cilium (d), percentage of cells with elongated primary cilium (e), and mean cilium length (f) were quantified. Error bars represent SEM; all experiments, 
n = 3 (for immunofluorescence, at least five fields of view imaged per experimental repeat). Student’s t test performed between groups: **, P < 0.01; 
***, P < 0.001; NS, not significant. Bars: (main) 10 µm; (insets) 5 µm.
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agy upon starvation, evidence suggests that persistent mTORC1 
simultaneously prevents senescent cells from realizing their 
full autophagic potential, which would otherwise lead to cell 
death. This seemingly contradictory role for autophagy as a 
prosurvival and cell death mechanism is a phenomenon also 
shown to contribute to tumorigenesis and neurodegeneration 
(Levine and Kroemer, 2008).
In addition to increased autophagy, we identified that con-
stitutive mTORC1 is supported by defects in sensing growth 
factor starvation. Specifically, senescent cells show defects in 
starvation-induced primary cilia growth (Bishop et al., 2010; 
Breslin et al., 2014) and, as a consequence, fail to efficiently 
suppress Akt and mTORC1 upon serum starvation (Boehlke et 
al., 2010; Wang et al., 2015). For the first time, we have shown 
that low plasma membrane potential supports these prosurvival 
signaling changes in senescence, restoration of which promoted 
starvation-induced cilia growth and thus Akt and mTORC1 in-
hibition. Despite these new insights, further work is required to 
fully realize the signaling and metabolic consequences of per-
turbed membrane potential in senescent cells, the underlying 
mechanisms that lead to this perturbation, and its relationship 
with other senescence-associated changes such as disrupted 
mitochondrial membrane potential (Miwa et al., 2014; Ziegler 
et al., 2015). It also remains unclear how membrane potential 
supports cilia growth and the mechanisms by which elongated 
cilia affect growth factor signaling. Exploring these causal and 
consequential interactions will undoubtedly improve our under-
standing of basic cell biology of senescence and in the wider 
areas of aging and ciliopathies.
Overall, our findings expand on the understanding of 
how mTORC1 is dysregulated in senescence and describe the 
underlying specific mechanisms of dysregulation, which may 
be targetable for senolytic interventions. This growing un-
derstanding has important implications for future health and 
lifespan interventions.
Materials and methods
All chemicals were from Sigma-Aldrich unless indicated otherwise.
Figure 3. Restoration of membrane potential in senescent cells promotes cilia elongation. (a) Resting and maximum membrane potential (maximum 
achieved by incubation for 5 min with 80 mM potassium gluconate) were measured in control and senescent (20 Gy irradiation; Sen (IR)) fibroblasts using 
DiSBAC2(3) dye. Depolarization is indicated by increased fluorescence. Data are represented relative to maximum. (b) Senescent cells treated as in a but 
in the presence or absence of 100 µM pinacidil overnight. (c and d) Senescent fibroblasts were treated with pinacidil overnight in serum-free medium. Cells 
were fixed and stained for acetylated tubulin (c). Percentage of cells with cilia and cilia length were quantified (d). (e) Senescent fibroblasts were starved 
of serum overnight and amino acids for 1 h in the presence or absence of pinacidil as indicated, lysed, and analyzed by immunoblot for mTORC1 activity. 
(f) Senescent fibroblasts were starved of serum overnight and amino acids for 1 h in the presence or absence of 50 µM autophagy inhibitor chloroquine 
(CQ), 10 µM Akt inhibitor, or both inhibitors as indicated. Cells were lysed and immunoblotted. Error bars represent SEM; all experiments, n = 3 (for im-
munofluorescence, at least five fields of view imaged per experimental repeat). Student’s t test performed between groups: **, P < 0.01; ***, P < 0.001; 
NS, not significant. Bars: (main) 10 µm; (insets) 5 µm.
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Cells and drug treatments
HeLa cells, primary human fibroblasts (MRC5), human diploid fi-
broblasts, TSC2-deficient (TSC2−/−) and wild-type (TSC2+/+) MEFs 
(gift from D.  Kwiatkowski, Harvard University, Cambridge, MA), 
and IFT88ORPK and control chondrocytes (gift from M. Knight, Queen 
Mary University of London, UK; see Wann et al., 2012, for spe-
cific culture and differentiation protocols) were cultured in DMEM 
(D6546) with 2 mM l-glutamine, 10% FBS, and 100 U/ml penicillin- 
streptomycin at 37°C, 5% CO2. In brief, TSC2−/− MEFs were pro-
duced from TSC2+/− or TSC2+/−TP53−/− intercrosses (Zhang et al., 
2003). Note these cells are TP53−/−. The original TSC2+/− MEFs 
were produced by electroporating a TSC2 targeting construct into J1 
embryonic stem cells. After confirmation of homologous recombina-
tion, successful clones were used to impregnate female mice (Onda 
et al., 1999). HeLa cells were incubated with 100 nM rapamycin 
overnight in serum-free media to monitor the effect of mTORC1 in-
hibition on cilia formation. Human fibroblasts were incubated with 
pinacidil (100  µM), Torin1 (200 nM; Tocris Bioscience), chloro-
quine (50  µM), and Akt inhibitor (1708-1; BioVisions; 10  µM for 
1 or 4 h, as indicated).
Senescence induction
Stress-induced senescence was achieved by exposing cells to 20 Gy 
irradiation using an X-rad225 irradiator (Precision X-ray, Inc.). Imme-
diately after irradiation, medium was refreshed and was changed every 
3 or 4 d for at least 30 d. Oncogene-induced senescence was induced 
by viral transduction of mutant B-RAFV600E (gift from D. Peeper, The 
Netherlands Cancer Institute, Amsterdam, Netherlands). Experiments 
were performed 10 d after transduction. Replicative senescence was 
achieved via replication exhaustion and defined by less than 0.5 popu-
lation doublings for at least 4 wks.
siRNA
ON-TAR GETplus SMA RTpool siRNA against human Atg5 (L-
004374-00) and nontargeting SMA RTpool siRNA (D-001810-10) 
were purchased from GE Healthcare. Final siRNA concentra-
tions of 100 nM were used for 96  h for silencing, and transfec-
tions were performed using DharmaFECT 2 (GE Healthcare) as 
per company instructions.
TSC2 Transduction
Overexpression of wild-type TSC2 was performed by lentiviral trans-
duction. The pLKO.1 WT TSC2 construct was a gift from B. Manning 
(Harvard School of Public Health, Cambridge, MA; Menon et al., 
2014). In brief, viruses were produced by the following protocol. 6 × 
106 HEK293FT cells were seeded 24 h before transfection in 10-cm 
dishes. Cells were transfected with control or WT TSC2 plasmid (5 µg) 
along with the packaging plasmids, VSV-G (2.5 µg), and Δ8.9 (3.75 µg) 
using Lipofectamine 2000 as per company instructions. Viruses were 
harvested 48 h after transfection, filtered, and incubated with senescent 
fibroblasts overnight. The virus-containing medium was replaced the 
next morning, and cells were left for a further 3 d before experiments.
Figure 4. Persistent Akt/mTORC1 signaling supports senescent cell survival and can be exploited to specifically promote cell death. (a and b) Senescent 
fibroblasts were starved of serum and amino acids overnight in the presence or absence of the mTOR kinase inhibitor 200 nM Torin1 (overnight), 50 µM 
autophagy inhibitor chloroquine (CQ; 4 h), or 10 µM Akt inhibitor (4 h) as indicated. Cells were incubated with fluorescent ReadyProbe Cell Viability 
reagents (a), and percentage cell death was quantified (b). (c) Control or senescent (20 Gy irradiation; Sen(IR)) fibroblasts were starved of serum and 
amino acids in the presence or absence of 200 nM Torin1 for 24 h. Cells were incubated with fluorescent ReadyProbe Cell Viability reagents, and cell 
viability was quantified (c). (d) Senescent fibroblasts were starved in the presence or absence of Torin1. Cells were lysed and analyzed for markers of 
apoptosis (PARP and cleaved caspase-3) and autophagy (p62 and LC3). (e) Senescent fibroblasts were starved in the presence or absence of Torin1 and 
chloroquine as indicated. Percentage cell death was analyzed by ReadyProbe cell viability reagents. Error bars represent SEM; for all experiments, n = 
3 (for immunofluorescence, at least five fields of view imaged per experimental repeat). Student’s t test performed between groups: ***, P < 0.001; NS, 
not significant. Bar, 30 µm.
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Starvation and recovery protocols
Unless otherwise stated, serum starvation was performed overnight 
(18 h), and amino acid starvation (including in the presence of dialyzed 
FCS) was performed for 1 h (after one wash with PBS). Amino acid 
starvation was performed using RPMI without amino acids (US Bio-
logicals). For cell death assays, cells were starved of serum and amino 
acids for 24 h. FCS was dialyzed with cassettes of <2 kD cutoff as per 
company instructions (Thermo Fisher Scientific).
Immunoblotting
Immunoblotting was performed as described previously (Korolchuk et 
al., 2011; Carroll et al., 2016). In brief, cells were lysed in RIPA buffer 
(50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% sodium de-
oxycholate, and 0.1% SDS, supplemented with Halt protease and phos-
phatase inhibitors; 1861280; Thermo Fisher Scientific) on ice. Protein 
concentrations of lysates were measured using DC protein assay (500-
0112; Bio-Rad Laboratories), and equal amounts of protein (20–40 
µg) were subjected to SDS-PAGE and immunoblotted. The following 
primary antibodies were used: rabbit anti–phospho S6Ser235/236 (4856, 
1:2,000), rabbit anti-S6 (2217, 1:2,000), rabbit anti–phospho AktSer473 
(9271, 1:1,000), rabbit anti–phospho AktThr308 (4056, 1:1,000), Akt 
(9272, 1:1,000), rabbit anti–phospho 4E-BP1Thr37/46 (2855, 1:2,000), 
rabbit anti–phospho AMPKThr172 (2535, 1:1,000), rabbit anti–phospho 
TSC2Ser939 (3615S, 1:500), rabbit anti-p21 (2947, 1:1,000), rabbit anti- 
LC3B (3868, 1:2,000), rabbit anti-PARP (9532, 1:1,000), and rabbit 
anti–cleaved caspase-3Asp175 (9661, 1:1,000), all purchased from Cell 
Signaling Technology. Other antibodies used in this study include 
mouse anti–α-tubulin (12G10, 1:10,000; Developmental Studies Hy-
bridoma Bank), B-RAF (sc-5284, 1:2,000; Santa Cruz Biotechnology, 
Inc.), rabbit anti-Atg5 (A0856, 1:1,000; Sigma-Aldrich). Secondary 
antibodies conjugated to HRP were all used at 1:5,000 for 1 h at RT. 
Clarity western ECL substrate (Bio-Rad Laboratories) was used to vi-
sualize chemiluminescence on LAS4000 (Fujifilm). Quantification of 
blots was performed using ImageJ v. 1.41 (NIH).
Immunofluorescence
Immunofluorescence was performed essentially as described pre-
viously (Korolchuk et al., 2011; Carroll et al., 2016). In brief, cells 
were fixed in 4% formaldehyde in PBS for 10 min, permeabilized with 
0.5% Triton X-100 for 10 min, and blocked in normal goat serum/
PBS-Tween for 1 h, all at RT. The following primary antibodies were 
used: rabbit anti-mTOR (2972, 1:200; Cell Signaling Technology), 
rabbit anti-TSC2 (4308, 1:1,000; Cell Signaling Technology), mouse 
anti-Lamp1 (for human cells, 1:1,000; Abcam), rat anti-Lamp1 (for 
mouse cells, 1:1,000; Developmental Studies Hybridoma Bank), 
mouse anti–acetylated tubulin (T7451, 1:1,000; Sigma-Aldrich), and 
rabbit anti–phospho S6Ser235/236 (#4856, 1:200; Cell Signaling Technol-
ogy). Cells were washed and incubated with the appropriate secondary 
antibodies (1:1,000; Thermo Fisher Scientific) for 1 h at RT.
Plasma membrane potential was measured by live imaging con-
focal microscopy. Confocal images were collected on either an LSM 
510 META Confocal Microscope (ZEI SS) or an SP8 (Leica Biosys-
tems) using a 63× Plan-Apo/1.4-NA oil objective, at 37°C, 5% CO2. 
Proliferating and senescent fibroblasts were incubated with DMEM 
containing 0.5 µM DiSBAC2(3) (Thermo Fisher Scientific) in the pres-
ence or absence of pinacidil overnight. Images were acquired with 
either LSM v. 3.2 (ZEI SS) or LasX v. 2.9 (Leica Biosystems) using 
glass-bottom dishes (Willco) with cells in medium. The relative flu-
orescence from DisBAC2(3) (red emission, captured using a 560- to 
580-nm bandpass filter) increases as the cells take up more dye, relative 
to their membrane potential. Maximum depolarization was achieved 
by incubation with 80 mM potassium gluconate for 5 min. The resting 
membrane potential was normalized to this value. For immunofluores-
cence, coverslips were mounted on slides with Prolong Gold antifade 
reagent with DAPI (Thermo Fisher Scientific). Secondary antibodies 
were conjugated with Alexa Fluor 488 or 594. Images were captured 
using the Leica SP8 as described, with samples at RT. All analyses were 
performed in ImageJ using regions of interest to determine cell inten-
sity in the respective fluorescent channels. For DisBAC2(3) analysis, 
z-stack images containing the whole volume of the cell were flattened 
into maximum projections before analysis. For colocalization, z-stack 
images containing the whole volume of the cell were analyzed by co-
localization plugin after a threshold was applied. For presentation pur-
poses, stacks were z-projected to maximum intensity. Cell viability was 
assessed using Ready Probes (Thermo Fisher Scientific) as per com-
pany instructions. Cells were imaged on a DM-IL inverted fluorescence 
microscope (Leica Biosystems) equipped with an Invenio 3SII digital 
camera (3.0 Mpix Color CMOS; Indigo Scientific).
Liquid chromatography-mass spectrometry
HeLa cells were seeded (in triplicate) in six-well plates and cultured in 
standard DMEM until 90% confluent. Cells were treated as indicated. 
Cells were washed once with cold PBS and lysed (50% methanol/30% 
acetonitrile/20% dH2O) at a concentration of 2 × 106 cells/ml. Samples 
were vortexed for 45 s and centrifuged at 13,000 rpm. Cleared lysates 
were subjected to liquid chromatography-mass spectrometry (LC-MS) 
as follows, using a three-point calibration curve with universally labeled 
carbon-13/nitrogen-15 amino acids for quantification. Cell lysate (10 µl) 
solution was injected into an Accela 600 LC system coupled to an Ex-
active mass spectrometer (Thermo Fisher Scientific). Chromatographic 
separation was performed on a Sequant ZIC-HIL IC column (150 × 4.6 
mm, 3.5 µm; Merck) with mobile phase A (water) and B (acetonitrile) 
both consisting of 0.1% formic acid (vol/vol) at the flow rate of 0.3 ml/
min. A gradient elution program was used: mobile phase A increasing 
from 20 to 80% in 30 min and holding A at 92% for 5 min, followed 
by 10-min reequilibration with 20% A. The Exactive mass spectrometer 
was equipped with a heated electrospray ionization source and operated 
in an electrospray ionization–positive and –negative switching mode 
with a scan range of 70–1200 m/z at a resolution of 50,000. The obtained 
LC-MS raw data were converted into .mzML files with ProteoWizard 
and imported into MZMine 2.10 to conduct peak extraction, sample 
alignment, and metabolite identification.
Quantification and statistical analysis
Quantification of confocal images was performed using the colocal-
ization plugin in ImageJ to measure the colocalization between mTOR 
or TSC2 and the lysosomal protein Lamp1. A constant threshold was 
applied to all the images in the z-stack and for every image within 
each experiment. After application of the colocalization plugin, all 
channels were projected (maximum) and quantified using Analyze 
particle plugin (particles 5 pixels and larger were included). The data 
were expressed as a percentage of mTOR or TSC2 that colocalized 
with Lamp1. Quantification was performed on 20–40 cells per con-
dition in three independent experiments. Cilia were quantified using 
three different methods: first, the percentage of cells with cilia were 
manually counted; second, the percentage of cells with elongated cilia 
were manually counted (based on a threshold set by the counter); and 
third, the mean cilium length was determined (measured via ImageJ). 
All scoring and quantification were performed blinded, and >100 
cells were counted per slide. Quantification is based on at least three 
independent experiments unless otherwise stated. Quantification of 
immunoblots was performed using ImageJ. Two-tailed, unpaired Stu-
dent’s t tests were performed on experimental data from at least three 
individual experiments.
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Online supplemental material
Fig. S1 shows that resistance of PI3K/Akt/mTOR signaling occurs 
in senescent and cilia-deficient cells possibly via perturbation of 
TSC2 and mTOR localization. Fig. S2 shows that changes in plasma 
membrane potential and autophagy in senescence support persistent 
mTORC1 signaling. Fig. S3 shows targeting of persistent mTORC1 
signaling to promote senescent cell death.
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